SCHEMBL2632620

SCHEMBL2632620

COc1ccc(CCOC(=N)C(Cl)(Cl)Cl)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 1/20 0.42
CHRM1 P11229 1/20 0.42
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.41
RECQL P46063 1/20 0.41
HTT P42858 2/20 0.40
HPGD P15428 1/20 0.40
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
DBH P09172 1/20 0.39
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
FFAR1 O14842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2632438 0.89 MET (0.38) KMT2AMAPTMAPK1TSHRKDM4E
SCHEMBL1323237 0.89 MAPT (0.49) ALDH1A1KMT2AMAPTMEN1CYP1A2
SCHEMBL16481554 0.86 CYP1A2 (0.54) KMT2AMEN1GAACYP1A2CYP3A4
SCHEMBL2632435 0.85 CNR1 (0.35) ALDH1A1KMT2AAPP
SCHEMBL12296002 0.83 MAPT (0.44) CHRM5CHRM1ALDH1A1KMT2AMAPT
SCHEMBL12295983 0.83 MAPT (0.44) CHRM5CHRM1ALDH1A1KMT2AMAPT
SCHEMBL12810287 0.82 CHRM5 (0.45) CHRM5CHRM1ALDH1A1KMT2AMAPT
SCHEMBL12810220 0.82 ALDH1A1 (0.38) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL12328264 0.81 SIGMAR1 (0.46)
SCHEMBL12327945 0.81 HDAC1 (0.45) ALDH1A1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163938-B2 Aminocyclohexyl ether compounds and uses thereof CARDIOME PHARMA CORP. (CA) 2012-04-24 US disclosed
EP-2298735-A1 Aminocyclohexyl ether compounds and uses thereof Cardiome Pharma Corp. (CA) 2011-03-23 EP disclosed
US-20110004006-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF CARDIOME PHARMA CORP. (CA) 2011-01-06 US disclosed
US-7767830-B2 Aminocyclohexyl ether compounds and uses thereof CARDIOME PHARMA CORP. (CA) 2010-08-03 US disclosed
US-20070254945-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF CARDIOME PHARMA CORP. (CA) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004006-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF KCNH2, KCNC1, KCNH3 CHRM5 243/4885CHRM1 1145/4885ALDH1A1 1102/4885
US-20070254945-A1 AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF KCNH2, KCNC1, KCNH3 CHRM5 243/4885CHRM1 1145/4885ALDH1A1 1102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.